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The last few years have seen new developments to understand and tackle the significant public
health issue posed by chronic kidney disease (CKD). Established renal disease currently con-
sumes 2% of the UK National Health Service budget and predictions are that this figure will in-
crease significantly due to the rising number of people requiring renal replacement therapy
fuelled by the ageing population and the diabetes mellitus epidemic.
This paper reviews the scale of CKD and discusses the new developments such as staging, refer-
ral guidelines and new Department of Health incentives brought about to improve awareness.
The importance of Information Technology in assisting the management of renal disease is also
outlined. We identify various types of intervention which might be used to do this: feedback in an
educational context, the establishment of computerized decision support and enhancement of
the patient journey. Many principles may be extended to the management of any chronic dis-
ease. While new developments are necessary to improve care, wider implementation is required
to be able to see if improved outcomes are achieved.
Keywords. Chronic kidney disease, glomerular filtration rate, National Service Framework,
Quality and Outcomes Framework, Information Technology.
The prevalence of chronic kidney disease
The National Kidney Foundation—Kidney Disease
Outcomes Quality Initiatives from the USA has in-
troduced a simple categorization of chronic kidney
disease (CKD)1 (Table 1). This classification is based
upon the calculation of estimated glomerular filtration
rate (GFR) rather than using the traditional serum
creatinine (SCr) concentration to define the level of
impairment. SCr has long been recognized as a poor
marker of overall renal function and this is now ac-
knowledged by various guidelines and national bod-
ies2–4 who recommend determination of GFR using
the Modification of Diet in Renal Disease formula5 to
better estimate renal function.
The Third National Health and Nutrition Examina-
tion Survey determined that approximately 11% (19
million) of the US adult population have CKD.6 Using
the new stages of CKD stratification,1 6.5% (11.3 mil-
lion) people were estimated to have stages 1–2 CKD
and a further 5% (8.5 million individuals) stages 3,
4 and 5 CKD. In England, the New Opportunities
for Early Renal Intervention by Computerised Assess-
ment (NEOERICA) study7 reported a population
prevalence of 4.9% for stages 3–5 CKD using a tech-
nique of data extraction looking for SCr concentra-
tions from primary care databases.
Guidelines and kidney disease
Recent studies show that 30–50% of patients with
CKD die prematurely from cardiovascular disease
rather than progressing to end-stage renal disease.8,9
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Go et al.10 highlighted that CKD is an independent
predictor of cardiovascular disease, mortality and
hospitalization. Reduction of cardiovascular disease is
already being addressed in primary care through
hypertension treatment, cholesterol reduction, diabe-
tes control, smoking cessation education and exercise
advice. However, CKD is not widely recognized by
physicians to be an independent risk factor for cardio-
vascular disease and evidence-based treatment in this
group of patients is limited.7,11 Renal disease is often
wrongly considered a reason to avoid certain drugs
such as angiotensin-converting enzyme inhibitors when
in fact they are recommended by guidelines.
In 2005, the Department of Health published the sec-
ond part of the National Service Framework for renal
services, focussing on early identification and preven-
tion of progression of CKD.12 Subsequently, a joint
working group hosted by the Department of Health
published new guidelines for CKD management and
referral.2 These initiatives, together with the National
Frameworks for renal,12 diabetes,13 coronary heart dis-
ease14 and elderly care, underline the overlap between
these groups and point to the important concept of
chronic disease management integrated across primary
and secondary care.
Usefulness of CKD staging
A system of staging of kidney disease can allow for
improved patient management by alerting clinicians
to potential complications of CKD and dictating treat-
ment strategies: Reduction of proteinuria can reduce
the risk of progression of renal disease15 and patients
with proteinuria, in the earlier stages of CKD could
be targeted and treated earlier to prevent deteriora-
tion of their renal function. Some studies have sug-
gested that earlier anaemia treatment can reduce the
risk of development of left ventricular hypertrophy
and other cardiac complications.16,17 Patients classified
into stage 4 or 5 CKD with progressive renal disease
should be managed in care pathways that prepare
them for their choice of renal replacement therapy or
for conservative management.2
Referral and management of patients
with renal disease
The UK CKD guidelines2 provide a general outline of
who should be referred from primary care to nephrol-
ogy services (Table 2). The guidelines recommend re-
ferral of patients with stages 4 and 5 CKD and
selected individuals from stages 1 to 3 CKD. Given
that the majority of stages 1–3 (and many stage 4)
CKD patients do not have progressive renal impair-
ment, a large proportion can be managed in primary
care focussing on interventions which can delay pro-
gression of CKD and alleviate symptoms, such as
blood pressure reduction with renin–angiotensin sys-
tem blockade and management of anaemia and renal
osteodystrophy. Regular follow up for SCr checks as






1 Kidney damage with normal or raised GFR >90 3.3 Hypertension
± haematuria
± proteinuria
± other pathology, e.g. polycystic renal disease
2 Kidney damage with mild reduced GFR 60–89 3.0 Hypertension
± haematuria
± proteinuria
± other pathology, e.g. polycystic renal disease
3 Moderate reduced GFR 30–59 4.3a Hypertension Disorders of bone metabolism
(YCa++, [PO4, [parathyroid hormone)
Anaemia of chronic disease
Left ventricular hypertrophy









Ca++: serum calcium. K+: serum potassium. PO4: serum phosphate.
aNEOERICA UK prevalence 4.6%, 0.2%, 0.04% for stages 3–5, respectively; no data for stages 1–2 due to low recording of proteinuria information
on primary care databases.
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well as cardiovascular risk reduction would be re-
quired. It is recommended that individuals with stages
4–5 CKD should ideally be seen and managed in sec-
ondary care in order to plan and make provision for re-
nal replacement therapy (dialysis and transplantation).
The new Quality and Outcomes
Framework for renal disease
The Quality Management and Analysis System18 gives
GP practices and Primary Care Trusts in England objec-
tive feedback regarding the specific quality of care deliv-
ered to their patients. The system gauges the practices’
performance through the Quality Outcomes Framework
(QOF), measured against national achievement targets
detailed in the General Medical Services contract for
England.19 The QOF performances are based entirely
on primary care computer data and only data coded in
the computer system using a limited list of read codes
are counted towards achieving the quality target. These
data are collected automatically from all brands of GP
computer systems. After being aggregated centrally, they
are made publically available through the National
Health Service (NHS) Health and Social Care
Information Centre.20 In order to encourage continual
improvement in the clinical care of CKD patients, the
new QOF for CKD in England was introduced in Febru-
ary 2006.21 The QOF contains four indicators of care
(Table 3), each having the potential to enhance CKD
management. This raises the profile of CKD and may al-
low for an opportunity for education on the importance
of cardiovascular risk in CKD. Moreover, combined with
the use of the CKD guidelines, appropriate referral could
be enhanced.
Connecting for health
One of the aims of Connecting for Health,22 formerly
known as the National Programme for Information
Technology (IT), is to improve the patient experience
through the use of modern computer systems and net-
works. Connecting for Health has largely three main
goals, namely an electronic care records service for pa-
tients, the ability to book electronic appointments
(Choose and Book) and electronic prescribing. These
goals are reliant on the development of an efficient,
reliable underlying IT infrastructure. Secure connections
between GPs’ practices and secondary care will save
TABLE 2 Referral criteria for patients with CKD
Renal function status Referral
Immediate/urgent Routine
Acute kidney injury GFR fall >10 ml/min over 5 days Not applicable
Stage 5 CKD Newly detected Stable
Stage 4 CKD Newly detected Stable
Stage 3 CKD Haematuria
Any GFR Accelerated phase hypertension
 Hyperkalaemia (K+ > 6 mmol/l)
 Nephrotic syndrome
 Multisystem disease with renal involvement
 GFR fall > 15% on an ACEi/ARB
 Proteinuria (PCR >100 mg/mmol)
 Haematuria + proteinuria (PCR 30–100 mg/mmol)
 Urologically unexplained haematuria
 BP >150/90 mm Hg; on three anti-hypertensive agents
K+: serum potassium. ACEi/ARB: angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker. PCR: protein: creatinine ratio.
TABLE 3 The Quality and Outcomes Framework indicators for renal disease and potential benefits
Indicator (points) Benefits
1. Register of patients with stages 3–5 CKD (6 points)
 Large database creation for research purposes
 Identification of high risk individuals to enable earlier
management of risk e.g cardiovascular disease
 Placement of patient in appropriate management pathway
2. Percentage on CKD register with blood pressure record in the last
15 months (6 points)
 Improved blood pressure recording
3. Percentage on CKD register with blood pressure <140/85 measured
in the last 15 months (11 points)
 Improved treatment of elevated blood pressure
4. Percentage on CKD register treated with ACEi/ARB. (Unless
a contraindication or side effects are recorded) (4 points)
 Increased use of appropriate medications such as ACEi in CKD
ACEi/ARB: angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker.
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time and transform the way the NHS works. Informa-
tion will be able to be shared more quickly and securely.
This will support patient’s choice and allow first hospital
outpatient referrals to be made at a location and time
suitable to the patient.
Although the National IT program is not specific to
kidney disease, there are various ways it can be of use
to patients with CKD.
Making IT work for people with
renal disease
The renal services information strategy
The renal services information strategy on CKD, acute
renal failure and end of life care23 has been written to
complement and support the quality requirements of
part two of the National Service Framework for renal
services.
The main issues of the information strategy for
CKD are outlined in Table 4.
Integrating clinical records and calculating GFR
In the UK, computerization of practices has increased
substantially, currently at least 96% are computerized.24
The QOF, discussed above, has provided additional in-
centives for the GP to code data on their computer sys-
tem. IT links between surgeries and the hospital
pathology laboratory have enabled surgeries to receive
online laboratory results on patients. This comprehen-
sive access to all patient historical investigations plus
the use of read-coded information provides a wealth of
information for the user in terms of disease profile and
risk description. Individual patient risk for disease could
be assessed and this information could be fed back to
the GP to enhance evidence-based treatment. To fit in
with the QOF coming into effect, laboratories have been
asked by the Department of Health to implement esti-
mated GFR reporting for all patients who have had an
SCr test and, if available, to give an up to date estimate
of compliance with this recommendation.25
Where patients already have an SCr concentration
measured before this date, GPs may wish to ascertain
stability of renal function by assessing eGFR on older
results. This is an important factor to take into consid-
eration when following the CKD guidelines. A range
of tools are available to help them do this. Online
eGFR calculators together with links to recommended
guidelines are useful.26 Other tools include mobile
phone or personal digital assistant calculators, down-
loadable calculators and spreadsheets containing built-
in macros enabling whole practice population eGFR
calculations.27
Using computers to identify CKD: utilizing existing
patient information
Existing record systems in primary care have been
demonstrated to be reliable sources to identify kidney
disease.28 In the NEOERICA project,7 structured and
read-coded data were obtained from 12 GP surgeries
based in Kent, Surrey and Salford, using Morbidity In-
formation Query Export Syntax.29 Variables were ex-
tracted to identify the prevalence, co-morbidity and
medicines management of CKD. Eighty-three percent
of patient with diabetes had already had some mea-
sure of renal function checked and testing of renal
function increased exponentially with age (Fig. 1),
demonstrating that testing of high-risk groups is al-
ready occurring. A formal screening program for CKD
may therefore not necessarily be required as much of
the information required already exists in primary care.
Use of feedback to improve the quality of care
One of the features of the NEOERICA programme
was that practices were provided with feedback using
techniques developed over the last 10 years in the
Primary Care Data Quality Programme. Potential
markers of success, such as quantification of appropriate
referral and reduction of late referral of advanced
CKD, are some of the outcomes that could be fed back
to GPs. Feedback has been demonstrated to improve
the quality of chronic disease management especially
when given in an educational content.30
Clinical decision support systems
Clinical decision support systems are computer-based
applications that may be made available on local
TABLE 4 Aims of the renal services information strategy
To educate the general public on CKD and to increase awareness
especially in high-risk groups.
To identify patients in primary care at risk of developing CKD.
To make information available to patients diagnosed with CKD
empowering them to make decisions about their treatment and
ongoing management.
Ensuring that IT systems are set up to support the diagnosis of acute
kidney injury.
Ensuring that IT systems in primary care support the appropriate
referral of patients to nephrology.
To support patients and their relatives in making informed choices
about treatment options, including conservative management.
To provide decision support to secondary care clinicians from other










<45 45-55 55-65 65-75 75-85 >85 total
age bands
Recorded serum creatinine With CKD
FIGURE 1 NEOERICA study, population with SCr.
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computers or may be accessed via the internet. They
serve many purposes and can be utilized in many dif-
ferent ways:
 Differential diagnosis assists: These can exploit
information about current symptoms, laboratory re-
sults, radiology and medical records. A good exam-
ple of a diagnosis tool is ‘Isabel’,31 a paediatric
decision support system used in some UK hospitals.
 Alert and reminder systems: These can be used to
warn health care providers of potential adverse
occurrences. For example, alerts to significantly
abnormal blood results or drug interaction and
contraindication alerts at the time of medication
prescribing.
Alert systems have been shown to be of benefit to pa-
tients. In a recent randomized controlled trial from the
USA,32 a computer system was developed to highlight
patients at risk of developing deep vein thrombosis
when admitted to hospital. The argument for clinical
decision support systems was strengthened in a recent
review of 70 studies by Kawamoto et al.33 where such
systems improved clinical practice in 68% of trials.
There are a few caveats however; it is important to
realize that computer ‘tools’ only serve as an adjunct
to the decision-making process and should not replace
the physician. Decision support systems may also be
too time consuming to develop or modify as guidelines
evolve. In some cases, they may also be difficult to in-
corporate into the general practice daily care and may
have limited uptake by practitioners.34,35
A clinical decision support system for nephrology
Renal patients may often be investigated by several
specialists and also have biochemical and haematolog-
ical tests undertaken in the community as well as the
hospital. This can result in unnecessary duplication of
tests and moreover wastes the opportunities that would
follow from data integration. Reuse of test results
might save money and time and could become the basis
of an effective computer monitoring system provided
by a decision support system or ‘virtual nephrologist’,
linked to GP computer systems. A decision support
tool or so-called virtual nephrologist based upon the
current UK CKD guidelines is currently being devel-
oped.36 The main aim being the provision of timely but
unobtrusive advice about the interpretation of blood
test results, drug prescriptions, specialist referrals and
other clinical aspects of renal care.
Improving patient information: Renal Patient View
Renal Patient View37 is an online service developed to
provide patients with their individual diagnosis, treat-
ment, latest test results and correspondence informa-
tion. Patients are provided with their own login and
have the ability to view or share their information any
time of day. Such an approach has potential to en-
hance the patient experience and empower the patient
with up to date information on their treatment.
Sharing of information: Do Once and Share
The Do Once and Share programme38 aims to intro-
duce sharing of new IT knowledge among clinicians
and to reduce unnecessary duplication of work in IT
system development. With this programme, clinicians
can share new IT developments in their speciality at
a national level. These new IT approaches to care can
then be shared and implemented across the NHS, sav-
ing time and reducing duplication of effort. Expert
Systems and Renal Patient View are part of the Do
Once and Share programme.
Conclusion
The last few years have seen new developments in the
field of CKD and these will hopefully create an envi-
ronment of better understanding renal disease. New
guidelines, based upon GFR, have been released to as-
sist with CKD management. In England, financial in-
centives have been introduced in primary care to
improve recognition of CKD and its associated co-
morbidity. Primary care computer systems are able to
correctly identify and stratify of the proportion of the
population with CKD. New IT systems and devel-
opments can play an important role in the future, par-
ticularly by improving information exchange and the
creation of partnerships between primary and second-
ary care to ensure that the specialist service is used
appropriately. These partnerships might include feed-
back about the quality of care in CKD, ideally in an
educational context. IT systems are important. Not on-
ly can they allow for integration of records and provi-
sion of information for health care providers, but they
can empower patients too. Despite new developments
in creation of new strategies, a challenge remains; the
provision of an infrastructure to allow uptake of such
innovations by the health care community.
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